The introduction of genetically engineered (GE) crops into commercial agriculture has triggered significant debate concerning their social, ethical, and regulatory implications. While next-generation crop improvement technologies, including CRISPR-based genome editing and synthetic biology, offer promising solutions for food security, climate resilience, and sustainable farming, their adoption remains constrained by public perception, ethical concerns, and complex regulatory frameworks. This chapter explores the evolving landscape of genetically modified organisms (GMO) commercialization, analyzing how government policies, risk assessments, and intellectual property laws shape market accessibility. Additionally, it examines societal attitudes, ethical dilemmas related to biodiversity and consumer rights, and corporate influence on seed distribution. Emerging challenges, such as cross-border regulatory inconsistencies, misinformation, and the rise of non-GMO labeling trends, are discussed in the context of their impact on global food systems. Future perspectives emphasize the need for transparent communication, inclusive policy-making, and adaptive regulatory models that balance innovation with biosafety. Addressing these multidimensional challenges is crucial for leveraging next-generation GM crops to drive sustainable agricultural transformation while ensuring public trust and ethical responsibility.